Avalo Therapeutics Inc (AVTX)
9.50
-0.14
(-1.45%)
USD |
NASDAQ |
May 17, 16:00
9.50
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Max Drawdown (5Y): 99.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.98% |
March 31, 2024 | 99.98% |
February 29, 2024 | 99.98% |
January 31, 2024 | 99.98% |
December 31, 2023 | 99.96% |
November 30, 2023 | 99.92% |
October 31, 2023 | 99.90% |
September 30, 2023 | 99.90% |
August 31, 2023 | 99.90% |
July 31, 2023 | 99.78% |
June 30, 2023 | 99.59% |
May 31, 2023 | 98.14% |
April 30, 2023 | 98.14% |
March 31, 2023 | 98.14% |
February 28, 2023 | 97.09% |
January 31, 2023 | 96.58% |
December 31, 2022 | 96.58% |
November 30, 2022 | 96.58% |
October 31, 2022 | 96.58% |
September 30, 2022 | 96.58% |
August 31, 2022 | 96.54% |
July 31, 2022 | 96.54% |
June 30, 2022 | 96.54% |
May 31, 2022 | 96.54% |
April 30, 2022 | 94.31% |
Date | Value |
---|---|
March 31, 2022 | 91.25% |
February 28, 2022 | 90.83% |
January 31, 2022 | 91.55% |
December 31, 2021 | 91.55% |
November 30, 2021 | 91.55% |
October 31, 2021 | 91.55% |
September 30, 2021 | 91.55% |
August 31, 2021 | 91.55% |
July 31, 2021 | 91.55% |
June 30, 2021 | 91.55% |
May 31, 2021 | 91.55% |
April 30, 2021 | 91.55% |
March 31, 2021 | 91.55% |
February 28, 2021 | 91.55% |
January 31, 2021 | 91.55% |
December 31, 2020 | 91.55% |
November 30, 2020 | 91.55% |
October 31, 2020 | 91.55% |
September 30, 2020 | 91.55% |
August 31, 2020 | 91.55% |
July 31, 2020 | 91.55% |
June 30, 2020 | 91.55% |
May 31, 2020 | 91.55% |
April 30, 2020 | 91.55% |
March 31, 2020 | 91.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.83%
Minimum
Feb 2022
99.98%
Maximum
Jan 2024
94.28%
Average
91.55%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Imunon Inc | 99.38% |
iBio Inc | 99.97% |
Kodiak Sciences Inc | 99.15% |
Petros Pharmaceuticals Inc | -- |
Ocugen Inc | 99.96% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -89.98 |
Beta (5Y) | 1.211 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 152.2% |
Historical Sharpe Ratio (5Y) | -0.5024 |
Historical Sortino (5Y) | -1.138 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 53.13% |